机译:Myc Myc重排和Myc / Bcl2双表达,但不是原产地预测R-Check中的预后?处理的弥漫性大B细胞淋巴瘤
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
Department of HematopathologyUT MD Anderson Cancer CenterHouston TX USA;
cell‐of‐origin classification; diffuse large B‐cell lymphoma; double expresser; MYC rearrangement; prognosis;
机译:Myc Myc重排和Myc / Bcl2双表达,但不是原产地预测R-Check中的预后?处理的弥漫性大B细胞淋巴瘤
机译:BCL2,C-MYC和BCL6遗传异常,爱泼斯坦-巴尔病毒感染,CD5蛋白表达,生发中心B细胞/非生发中心B细胞亚型,MYC / BCL2蛋白的共表达和共表达的临床意义弥漫性大B细胞淋巴瘤中MYC / BCL2 / BCL6蛋白的表达:120例患者的临床和病理相关性研究
机译:原发性皮肤弥漫性大B细胞淋巴瘤,MYC-IGH重排并获得BCL2:扩大MYC / BCL2双命中淋巴瘤的频谱。
机译:通过深度学习预测弥漫性大B细胞淋巴瘤标本的MYC易位
机译:c-Myc在FOXO3a介导的抗IgM处理的WEHI 231 B细胞中p27(Kip1)表达调控中的作用。
机译:BCL2C-MYC和BCL6遗传异常爱泼斯坦-巴尔病毒感染CD5蛋白表达生发中心B细胞/非生发中心B细胞亚型MYC / BCL2蛋白的共表达和共表达的临床意义弥漫性大B细胞淋巴瘤中MYC / BCL2 / BCL6蛋白的表达:120例患者的临床和病理相关性研究
机译:利妥昔单抗-CHOP治疗弥漫性大B细胞淋巴瘤患者与 MYC i>重排和Myc过表达相关的临床特征,肿瘤生物学和预后